Invest Michigan
  • Home
  • About
  • Team
  • Portfolio
  • Press
  • Contact

Genomenon, Nostos Genomics to Integrate Technologies to Improve Rare Disease Dx

June 1, 2021

This is an article about portfolio company, Genomenon.

NEW YORK – Genomenon said Tuesday that it has partnered with German bioinformatics startup Nostos Genomics to integrate its Mastermind genomic search engine into the Nostos AIon AI-driven variant interpretation platform.

According to Ann Arbor, Michigan-based Genomenon, this integration will allow AIon users to preview lists of published articles related to their searches from within the AIon interface. This, the companies said, will help improve diagnosis of rare genetic diseases.

View source version on genomeweb.com: https://www.genomeweb.com/business-news/genomenon-nostos-genomics-integrate-technologies-improve-rare-disease-dx#.YO9ZmpNKhpQ

Newer
All
Older

Contact

Invest Michigan
235 E. Main Street, Suite 105B
Northville, MI 48167
Email info@investmichigan.org
© 2025 Invest Michigan Powered by Jottful